Warning (512): /home/pharma/website/current/cakephp/app/pharmalicensing/tmp/cache/ is not writable [CORE/cake/libs/cache/file.php, line 267]
Code
        if ($this->_init && !is_writable($this->settings['path'])) {
            $this->_init = false;
            trigger_error(sprintf(__('%s is not writable', true), $this->settings['path']), E_USER_WARNING);
FileEngine::__active() - CORE/cake/libs/cache/file.php, line 267
FileEngine::init() - CORE/cake/libs/cache/file.php, line 94
Cache::_buildEngine() - CORE/cake/libs/cache.php, line 151
Cache::config() - CORE/cake/libs/cache.php, line 126
include - /home/pharma/website/releases/20120317114903/cakephp/app/pharmalicensing/config/core.php, line 345
Configure::__loadBootstrap() - CORE/cake/libs/configure.php, line 391
Configure::getInstance() - CORE/cake/libs/configure.php, line 52
include - CORE/cake/bootstrap.php, line 38
[main] - /home/pharma/website/releases/20120317114903/cakephp/webroot/pharmalicensing/index.php, line 100

• Home
• Licensing Center
  • Data Center
    • Out-licensing
    • In-licensing
    • Companies
    • Services
  • Reports
  • Newsletter
    • Subscribe
    • Partnering Update
    • Key Reports
    • Pharmalicensing Recommends
  • Pharmalicensing Intelligence
    • Industry News
    • Deals Review
    • Press Releases
    • Articles
  • Profiled Companies
  • Events
• Our Services
  • Partnering Search
  • Company Profiling
  • Reports
  • Pharma Transfer
  • Deal Negotiation
  • Pharmalicensing Intelligence
• About us
  • Case Studies
  • Our Audience
  • FAQ
  • Directions
  • MedicalDeviceLicensing.com
  • Innovaro Corporate
• Contact us

Login    Register

Search

Industry news

• Industry news
• Intellectual Property
• News

StemCells, Inc's Technology Used to Create First Genetically Engineered Rat Derived from Rat Embryonic Stem Cells

In order to access this content you must be logged in and have a subscription to Pharmalicensing Intelligence.

Pharmalicensing Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.

Subscribe now for instant access to the benefits Pharmalicensing Intelligence has to offer. Find out more.

Request a demo of
Pharmalicensing Intelligence

Company details

If you want to find out more about the company visit StemCells profile.

Related reports

Market Research Reports provided by reports.innovaro.com

StemCells, Inc. (STEM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mar 2011 - 95 pages - $250

Emerging Technologies: Stem cells

Nov 2011 - 61 pages - $3,800

Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development

Mar 2008 - 250 pages - $3,995

Opportunities in Stem Cell Research and Commercialization: Technology advances, regulatory impact and key players

Mar 2006 - 207 pages - $2,875

StemCells, Inc. (STEM) - Financial and Strategic SWOT Analysis Review

May 2011 - 25 pages - $250

Global Stem Cell and Advanced Technologies Market

Nov 2009 - 229 pages - $4,650

Orthopedic Biomaterials, The World Market

May 2011 - 250 pages - $3,995

Future Directions in Regenerative Medicine

Feb 2011 - 184 pages - $3,835

Stem Cell Therapeutics Markets

Feb 2008 - 150 pages - $2,500

Engineered Arresting Systems Corporation: SWOT Analysis & Company Profile

Jan 2011 - 12 pages - $99

More Related Market Research Reports >>>

Related news

Latest News

SEMBIOSYS ISSUED KEY U.S. PATENT FOR THE PRODUCTION OF APOLIPOPROTEINS IN PLANTS

StemCells, Inc's Technology Used to Create First Genetically Engineered Rat Derived from Rat Embryonic Stem Cells

Marina Biotech Announces Allowance of Fundamental RNAi Delivery Patent From U.S. Patent Office

Sequella and University of Maryland Restate Exclusive License for Jointly-owned Event Marker System Technology

Ranier Technology announces the European Patent Grant on its Precision Polyurethane Manufacturing (PPM) Technology

More news... | RSS Feed...

Most Viewed

SEMBIOSYS ISSUED KEY U.S. PATENT FOR THE PRODUCTION OF APOLIPOPROTEINS IN PLANTS

Marina Biotech Announces Allowance of Fundamental RNAi Delivery Patent From U.S. Patent Office

StemCells, Inc's Technology Used to Create First Genetically Engineered Rat Derived from Rat Embryonic Stem Cells

Sequella and University of Maryland Restate Exclusive License for Jointly-owned Event Marker System Technology

Ranier Technology announces the European Patent Grant on its Precision Polyurethane Manufacturing (PPM) Technology

Therapeutic Target

Cardiovascular

Dermatology

Endocrine and Metabolic

Gastroenterology

Genitourinary

Hematology

Immunology and Allergy

Infection

Musculoskeletal

Neurology

Obstetrics and Gynecology

Oncology

Ophthalmology

Psychiatry

Pulmonary

Categories

Deals and Alliances

Development

Financial Results

Financings

Intellectual Property

Regulatory

Press releases

Deals review

Headlines

PR Newswire

Products:	Partnering Search	Company Profiling	Pharmalicensing Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Industrial Sector	Therapeutic Target	Articles date
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	FAQ	Contact us	Site map

© Copyright 1998-2012 Innovaro Europe Ltd All rights reserved. Terms and Conditions | Contact us